LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION March 31, 2015 TO: Honorable Charles Schwertner, Chair, Senate Committee on Health & Human Services FROM: Ursula Parks, Director, Legislative Budget Board IN RE:SB542 by Kolkhorst (Relating to the prescription and pharmaceutical substitution of biological products.), As Introduced No fiscal implication to the State is anticipated. Local Government Impact No fiscal implication to units of local government is anticipated. Source Agencies:515 Board of Pharmacy LBB Staff: UP, NB, NV, TWh
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 84TH LEGISLATIVE REGULAR SESSION
March 31, 2015
TO: Honorable Charles Schwertner, Chair, Senate Committee on Health & Human Services FROM: Ursula Parks, Director, Legislative Budget Board IN RE:SB542 by Kolkhorst (Relating to the prescription and pharmaceutical substitution of biological products.), As Introduced
TO: Honorable Charles Schwertner, Chair, Senate Committee on Health & Human Services
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: SB542 by Kolkhorst (Relating to the prescription and pharmaceutical substitution of biological products.), As Introduced
Honorable Charles Schwertner, Chair, Senate Committee on Health & Human Services
Honorable Charles Schwertner, Chair, Senate Committee on Health & Human Services
Ursula Parks, Director, Legislative Budget Board
Ursula Parks, Director, Legislative Budget Board
SB542 by Kolkhorst (Relating to the prescription and pharmaceutical substitution of biological products.), As Introduced
SB542 by Kolkhorst (Relating to the prescription and pharmaceutical substitution of biological products.), As Introduced
No fiscal implication to the State is anticipated.
No fiscal implication to the State is anticipated.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: 515 Board of Pharmacy
515 Board of Pharmacy
LBB Staff: UP, NB, NV, TWh
UP, NB, NV, TWh